These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23343007)

  • 1. Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester.
    Kim SY; Park SY; Kim MJ; Lee BY; Han JY; Ryu HM
    J Matern Fetal Neonatal Med; 2013 Jun; 26(9):860-5. PubMed ID: 23343007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia.
    Zeng X; Sun Y; Yang HX; Li D; Li YX; Liao QP; Wang YL
    Am J Obstet Gynecol; 2009 Dec; 201(6):618.e1-7. PubMed ID: 19766985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
    J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The predictive value of plasma fibronectin concentration on fetal growth retardation and preeclampsia at earlier stage of the third trimester].
    Xiong G; Wang Z; Yu Q
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):734-7. PubMed ID: 16136894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
    Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
    Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
    He Y; Chen S; Huang H; Chen Q
    J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Follistatin-like-3 was elevated in second trimester of pregnant women who subsequently developed preeclampsia.
    Han X; He J; Wang A; Dong M
    Hypertens Pregnancy; 2014 Aug; 33(3):277-82. PubMed ID: 24475769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.
    Chavarría ME; Lara-González L; García-Paleta Y; Vital-Reyes VS; Reyes A
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):157-64. PubMed ID: 17706337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
    J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of immunoglobulin E and the subsequent risk of pre-eclampsia: a population-based study.
    Eskild A; Nilsen TI; Jeansson S; Jenum PA; Vatten LJ
    Acta Obstet Gynecol Scand; 2008; 87(3):373-6. PubMed ID: 18307080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.
    McElrath TF; Lim KH; Pare E; Rich-Edwards J; Pucci D; Troisi R; Parry S
    Am J Obstet Gynecol; 2012 Nov; 207(5):407.e1-7. PubMed ID: 22981320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia.
    Yu CK; Papageorghiou AT; Bindra R; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):158-62. PubMed ID: 15590441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.
    Zhong XY; Holzgreve W; Hahn S
    Hypertens Pregnancy; 2002; 21(1):77-83. PubMed ID: 12044339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of early-pregnancy plasma malondialdehyde concentration and risk of preeclampsia.
    Rudra CB; Qiu C; David RM; Bralley JA; Walsh SW; Williams MA
    Clin Biochem; 2006 Jul; 39(7):722-6. PubMed ID: 16603146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.